In the medium term, the approach should contribute to the development of treatments for paralytic diseases such as infantile spinal muscular amyotrophy or amyotrophic lateral sclerosis.

Part of the profits from the sales of the headphones and stand will be donated to the P’tit LOUIS association, dedicated to saving 8-year-old Louis Biscini who su ers from a rare degenerative disease: spinal muscular atrophy type 1.

Part of the profits from the sales of the headphones and stand will be donated to the P’tit LOUIS association, dedicated to saving 8-year-old Louis Biscini who su ers from a rare degenerative disease: spinal muscular atrophy type 1.

Respiratory compromise in children with infantile-onset (consistent with Type I) spinal muscular atrophy may be differentiated into 3 categories3 :

Genomic Vision presents the initial results of the pilot study undertaken with quest diagnostics in spinal muscular atrophy

The case of infantile spinal muscular atrophy is a good illustration of what gene therapy can currently achieve in situations of major therapeutic deficiency.

In the medium term, the approach should contribute to the development of treatments for paralytic diseases such as infantile spinal muscular amyotrophy or amyotrophic lateral sclerosis.

SMA Type I: The most severe form, is also known as Infantile Spinal Muscular Atrophy or Werdnig-Hoffmann disease.

For individuals with infantile-onset (Type 1) and presymptomatic SMA results showed marked improvements in muscle function.

At the same time, we are continuing to make progress on the test jointly developed with Quest Diagnostics for detecting “healthy” carriers of infantile Spinal Muscular Atrophy.

In the medium term, the approach should contribute to the development of treatments for paralytic diseases such as infantile spinal muscular amyotrophy or amyotrophic lateral sclerosis.

In the medium term, the approach should contribute to the development of treatments for paralytic diseases such as infantile spinal muscular amyotrophy or amyotrophic lateral sclerosis.

Genomic Vision Presents the Initial Results of the Pilot Study Undertaken with Quest Diagnostics in Spinal Muscular Atrophy (SMA) at the ASHG 2016 Annual Meeting in Vancouver

GENOMIC VISION and ROUEN University Hospital launch genomic biomarker identification trial to improve genetic counseling for Infantile Spinal Muscular Atrophy in France

Part of the profits from the sales of the headphones and stand will be donated to the P’tit LOUIS association, dedicated to saving 8-year-old Louis Biscini who su ers from a rare degenerative disease: spinal muscular atrophy type 1.

enrolment by Rouen University Hospital of the first patients in the clinical trial on the infantile SMA (Spinal Muscular Atrophy) test developed by Genomic Vision and selected by Quest Diagnostics as one of the jointly developed tests.